10.03.2010 12:00:00
|
Astra Tech launches OsseoSpeed™ TX implant line at the Academy of Osseointegration Annual Meeting
Astra Tech, leading provider of comprehensive solutions for dental implant therapy, launched their OsseoSpeed™ TX implant line to the US market at this year’s AO Annual Meeting. The OsseoSpeed™ TX implant comes as the next step in the continuous evolution of the Astra Tech Implant System™ with its modified tapered apex design, first introduced with the launch of their narrow two-piece implant, OsseoSpeed™ TX 3.0 S in June 2008. This new design modification allows for easier implant installation in all indications, especially in soft bone where under-preparation is often desired.
Ensuring optimal long-term esthetic results, all key features of the Astra Tech BioManagement Complex™, including OsseoSpeed™ fluoride-modified surface, MicroThread™ at the implant neck, a Conical Seal Design™ and the Connective Contour™ are maintained.
"We are extremely pleased with the overwhelming, positive response to this new design modification, received during the AO Annual Meeting,” states Scott Root, President and CEO, Astra Tech North America. "We are confident that this new modification will help to further simplify the implant treatment procedure for all our customers while still delivering the optimal results they’ve come to expect.”
About the Astra Tech Implant System™
The Astra Tech Implant System™ allows for full flexibility to meet the needs of every clinical situation whether one- or two-stage surgery, immediate placement or immediate load protocols, and in all bone qualities. In over 40 published articles, it is well documented that when using the Astra Tech Implant System, the mean marginal bone level reduction is only 0.3 millimeters during the first year of loading and maintained thereafter. These results are at least four times better when compared to the current standard norm of 1.5 mm marginal bone loss after five years.*
To learn more about OsseoSpeed™ TX or other Astra Tech products and services, call 800-531-3481 or visit www.astratechdental.com.
* References available upon request.
About Astra Tech
Astra Tech AB, a company in the AstraZeneca group, develops, manufactures, markets dental implants and advanced disposable products for use within healthcare. The company develops products that enhance treatment results, simplify work for healthcare professionals and help cut healthcare costs.
Astra Tech’s headquarters and production facilities are located in Mölndal, near Gothenburg, Sweden. The company operates globally through 16 subsidiaries as well as additional distribution partners. In North America, it is represented by Astra Tech Inc., 590 Lincoln Street, Waltham, MA 02451.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6208454&lang=en
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu AstraZeneca PLC (spons. ADRs)mehr Nachrichten
12.11.24 |
AstraZeneca-Aktie verliert: AstraZeneca steigert Umsatz im 3. Quartal und hebt Ausblick für 2024 an (Dow Jones) | |
11.11.24 |
Ausblick: AstraZeneca gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) | |
07.11.24 |
AstraZeneca-Aktie tiefer: AstraZenecas China-Chef festgenommen - Behörden ermitteln (Dow Jones) | |
06.11.24 |
Pluszeichen in New York: NASDAQ 100 mit Gewinnen (finanzen.at) | |
05.11.24 |
Zuversicht in New York: Schlussendlich Gewinne im NASDAQ 100 (finanzen.at) | |
05.11.24 |
Börse New York in Grün: So steht der NASDAQ 100 am Nachmittag (finanzen.at) | |
05.11.24 |
Zuversicht in New York: NASDAQ 100 am Mittag auf grünem Terrain (finanzen.at) | |
05.11.24 |
Pluszeichen in New York: NASDAQ 100 legt zum Start des Dienstagshandels zu (finanzen.at) |